Report Summary
The global 10-Valent Pneumococcal Polysaccharide Vaccine market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the 10-Valent Pneumococcal Polysaccharide Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of 10-Valent Pneumococcal Polysaccharide Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of 10-Valent Pneumococcal Polysaccharide Vaccine in these regions.
This research report categorizes the global 10-Valent Pneumococcal Polysaccharide Vaccine market by top players/brands, region, type and end user. This report also studies the global 10-Valent Pneumococcal Polysaccharide Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GSK
Market size by Product
Single Dose Vial
Pre-filled Syringe
Market size by End User
Hospital
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global 10-Valent Pneumococcal Polysaccharide Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of 10-Valent Pneumococcal Polysaccharide Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global 10-Valent Pneumococcal Polysaccharide Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of 10-Valent Pneumococcal Polysaccharide Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of 10-Valent Pneumococcal Polysaccharide Vaccine are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of 10-Valent Pneumococcal Polysaccharide Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 10-Valent Pneumococcal Polysaccharide Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Product
1.4.2 Single Dose Vial
1.4.3 Pre-filled Syringe
1.5 Market by End User
1.5.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size
2.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2027
2.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2027
2.2 10-Valent Pneumococcal Polysaccharide Vaccine Growth Rate by Regions
2.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Regions
2.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
3.1.1 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
3.1.2 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers
3.1.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers
3.2.1 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2017-2020)
3.2.2 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2017-2020)
3.3 10-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturers
3.4 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Product Types
3.4.1 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers 10-Valent Pneumococcal Polysaccharide Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into 10-Valent Pneumococcal Polysaccharide Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Product
4.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Product
4.3 10-Valent Pneumococcal Polysaccharide Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Breakdown Data by End User
6 North America
6.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine by Countries
6.1.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries
6.1.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine by Product
6.3 North America 10-Valent Pneumococcal Polysaccharide Vaccine by End User
7 Europe
7.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine by Countries
7.1.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries
7.1.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine by Product
7.3 Europe 10-Valent Pneumococcal Polysaccharide Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine by Countries
8.1.1 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries
8.1.2 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine by Product
8.3 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine by End User
9 Central & South America
9.1 Central & South America 10-Valent Pneumococcal Polysaccharide Vaccine by Countries
9.1.1 Central & South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries
9.1.2 Central & South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America 10-Valent Pneumococcal Polysaccharide Vaccine by Product
9.3 Central & South America 10-Valent Pneumococcal Polysaccharide Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine by Countries
10.1.1 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Countries
10.1.2 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine by Product
10.3 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine by End User
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 Company Business Overview
11.1.3 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2020)
11.1.4 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Products Offered
11.1.5 GSK Recent Development
12 Future Forecast
12.1 10-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Regions
12.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Regions 2021-2027
12.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Regions 2021-2027
12.2 10-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Product
12.2.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Product 2021-2027
12.2.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Product 2021-2027
12.3 10-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by End User
12.4 North America 10-Valent Pneumococcal Polysaccharide Vaccine Forecast
12.5 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Forecast
12.6 Asia Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Forecast
12.7 Central & South America 10-Valent Pneumococcal Polysaccharide Vaccine Forecast
12.8 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 10-Valent Pneumococcal Polysaccharide Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
